My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 676

1.

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.

Tapper W, Hammond V, Gerty S, Ennis S, Simmonds P, Collins A; Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering Group, Eccles D.

Breast Cancer Res. 2008;10(6):R108. Epub 2008 Dec 18.PMID: 19094228 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, González-Neira A, Benítez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dörk T, Schürmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomäki K, von Smitten K, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengström M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Australian Ovarian Cancer Management Group, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Klijn JG, Hooning MJ, Meijers-Heijboer H, Collee JM, van den Ouweland A, Uitterlinden AG, Liu J, Lin LY, Yuqing L, Humphreys K, Czene K, Cox A, Balasubramanian SP, Cross SS, Reed MW, Blows F, Driver K, Dunning A, Tyrer J, Ponder BA, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gabrieau V, Sigurdson A, Doody M, Struewing JP, Alexander B, Easton DF, Pharoah PD.

PLoS Genet. 2008 Apr 25;4(4):e1000054.PMID: 18437204 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Association of breast cancer susceptibility variants with risk of pancreatic cancer.

Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3044-8. Epub 2009 Oct 20.PMID: 19843670 [PubMed - indexed for MEDLINE]Related articles

4.

Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.

Udler MS, Azzato EM, Healey CS, Ahmed S, Pooley KA, Greenberg D, Shah M, Teschendorff AE, Caldas C, Dunning AM, Ostrander EA, Caporaso NE, Easton D, Pharoah PD.

Int J Cancer. 2009 Dec 1;125(11):2687-96.PMID: 19551860 [PubMed - indexed for MEDLINE]Related articles

5.

ESR1 and EGF genetic variation in relation to breast cancer risk and survival.

Einarsdóttir K, Darabi H, Li Y, Low YL, Li YQ, Bonnard C, Sjölander A, Czene K, Wedrén S, Liu ET, Hall P, Humphreys K, Liu J.

Breast Cancer Res. 2008;10(1):R15. Epub 2008 Feb 14.PMID: 18271972 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.

Woolcott CG, Maskarinec G, Haiman CA, Verheus M, Pagano IS, Le Marchand L, Henderson BE, Kolonel LN.

Breast Cancer Res. 2009;11(1):R10. Epub 2009 Feb 21.PMID: 19232126 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.

Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, vd Ouweland A, Menke-Pluymers MB, Bartels CC, Kriege M, van Geel AN, Burger CW, Eggermont AM, Meijers-Heijboer H, Klijn JG.

Eur J Cancer. 2007 Mar;43(5):867-76. Epub 2007 Feb 20.PMID: 17307353 [PubMed - indexed for MEDLINE]Related articles

8.

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.

Huijts PE, Vreeswijk MP, Kroeze-Jansema KH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Wijers-Koster PM, Blom JC, Pooley KA, Klijn JG, Tollenaar RA, Devilee P, van Asperen CJ.

Breast Cancer Res. 2007;9(6):R78.PMID: 17997823 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.

BMC Cancer. 2005 Jul 19;5:81.PMID: 16029503 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Chen YC, Kraft P, Bretsky P, Ketkar S, Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H, Burtt N, Bueno-de-Mesquita B, Cann H, Canzian F, Chanock S, Dunning A, Feigelson HS, Freedman M, Gaziano JM, Giovannucci E, Sánchez MJ, Haiman CA, Hallmans G, Hayes RB, Henderson BE, Hirschhorn J, Kaaks R, Key TJ, Kolonel LN, LeMarchand L, Ma J, Overvad K, Palli D, Pharaoh P, Pike M, Riboli E, Rodriguez C, Setiawan VW, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Virtamo J, Trichopoulou A, Wacholder S, Weinstein SJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1973-81.PMID: 17932344 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

BMC Med Genet. 2007 Dec 1;8:72.PMID: 18053149 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.

Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M.

Breast Cancer Res. 2008;10(4):R57. Epub 2008 Jul 8.PMID: 18611262 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.

Clin Cancer Res. 2005 Jul 1;11(13):4775-8.PMID: 16000574 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.

Milne RL, Ribas G, González-Neira A, Fagerholm R, Salas A, González E, Dopazo J, Nevanlinna H, Robledo M, Benítez J.

Cancer Res. 2006 Oct 1;66(19):9420-7.PMID: 17018596 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.

Prentice RL, Huang Y, Hinds DA, Peters U, Pettinger M, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3079-85. Epub 2009 Oct 27.PMID: 19861516 [PubMed - indexed for MEDLINE]Related articles

16.

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.

Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X; Australian Cancer (Ovarian) Study; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson S, Schildkraut JM, Berchuck A, Iversen ES, Moorman PG, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Anton-Culver H, Ziogas A, Brewster WR, Ponder BA, Easton DF, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC).

Hum Mol Genet. 2009 Jun 15;18(12):2297-304. Epub 2009 Mar 20.PMID: 19304784 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.

Azzato EM, Driver KE, Lesueur F, Shah M, Greenberg D, Easton DF, Teschendorff AE, Caldas C, Caporaso NE, Pharoah PD.

Breast Cancer Res. 2008;10(3):R47. Epub 2008 May 28.PMID: 18507837 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.

Kawase T, Matsuo K, Suzuki T, Hiraki A, Watanabe M, Iwata H, Tanaka H, Tajima K.

Int J Cancer. 2009 Oct 15;125(8):1946-52.PMID: 19582883 [PubMed - indexed for MEDLINE]Related articles

19.

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

BMC Cancer. 2009 Sep 18;9:331.PMID: 19765277 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.

Gail MH.

J Natl Cancer Inst. 2008 Jul 16;100(14):1037-41. Epub 2008 Jul 8.PMID: 18612136 [PubMed - indexed for MEDLINE]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk